Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 9Blood Specimen Collection 9Radiotherapy 7Surveys and Questionnaires 6Surgical Procedures, Operative 4vorasidenib 3Temozolomide 3Aminolevulinic Acid 3X-Rays 2Watchful Waiting 2Polymerase Chain Reaction 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2Fluorodeoxyglucose F18 2Diagnostic Imaging 2Cancer Vaccines 2Amplified Fragment Length Polymorphism Analysis 2vinyltriethoxysilane 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadoterate meglumine 1gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate 1fluorodopa F 18 1fluarix 1apatinib 1Ultrasonography 1Transurethral Resection of Bladder 1Trail Making Test 1Tetanus Toxoid 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Glioma × fluarix × Clear all
NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Wake Forest University Health Sciences

Completed
55 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡